GlassScriptPhysician profile
Sarah Mchugh
NPI 1902637739
$414.77
in general payments reported to CMS, 2019-2025
13 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $57.63 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $82.23 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $44.13 | 2025 | Gemtesa |
| Urogen Pharma, INC. | $38.87 | 2025 | |
| Endo USA, INC. | $35.74 | 2025 | Xiaflex, Aveed |
| Convatec INC. | $35.42 | 2025 | |
| Immunitybio, INC. | $31.37 | 2025 | |
| Photocure INC | $31.25 | 2025 | Cysview |
| Abbvie INC. | $24.32 | 2025 | |
| Janssen Biotech, INC. | $19.78 | 2025 | Erleada |
| Vertex Pharmaceuticals Incorporated | $19.27 | 2025 | |
| Tempus Ai, INC | $19.10 | 2025 | Xt Cdx |
| Teleflex LLC | $17.95 | 2025 | Urolift |
| Merck Sharp & Dohme LLC | $15.34 | 2025 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Mchugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.